当前位置:APASL-en-亚太肝脏研究协会年会 >> 正文
[APASL2013]48 Weeks of Therapy Might Not Be Needed for the Patients with HCV Genotype 2 without RVR like EASL Guideline
—— 作者: 时间:2013-06-07
阅读数:
238
简介:EASL guideline recommended that patients who have an early virological response (EVR), i.e. HCV RNA which is detectable at week 4 but undetectable at week 12 should be treated at 48 weeks regardless if the HCV genotypes.
请登录后查看详细内容
标签:
摘要赏析
摘要赏析
丙肝
发表评论
全部评论